This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Charles Rudin: Innovator in Oncotherapy
Introduction
Charles Rudin is a prominent inventor known for his contributions to the field of oncology. He is currently affiliated with the Memorial Sloan Kettering Cancer Center, where he focuses on innovative cancer therapies. His work has significant implications for the treatment of various cancers, particularly through targeted therapies.
Latest Patents
One of Charles Rudin's notable patents is the "Seneca Valley Virus (SVV) Cellular Receptor Targeted Oncotherapy." This patent represents a significant advancement in the development of targeted cancer treatments, showcasing his commitment to improving patient outcomes.
Career Highlights
Throughout his career, Charles Rudin has made substantial contributions to cancer research and therapy. His work at the Memorial Sloan Kettering Cancer Center has positioned him as a leader in the field, where he continues to explore innovative approaches to cancer treatment.
Collaborations
Charles Rudin has collaborated with esteemed colleagues, including John Poirier and Linde Miles. These partnerships have fostered a collaborative environment that enhances research and development in oncotherapy.
Conclusion
In summary, Charles Rudin is a dedicated inventor whose work in oncotherapy is paving the way for new treatment options in cancer care. His innovative approach and collaboration with other experts in the field continue to drive advancements in this critical area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile